Shares in Tandem Diabetes Care (NSDQ:TNDM) fell -3% today after the insulin pump maker topped revenue expectations, but missed earnings estimates on Wall Street with its first-quarter results.
The San Diego, Calif.-based company posted a net loss of -$32.7 million, or -$1.82 per share, on sales of $27.3 million for the 3 months ended March 31, for bottom-line loss of -37% on sales growth of 44% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Sales for Tandem Diabetes Care climb 44% in Q1 appeared first on MassDevice.